P6620

Overview

P6620 is an orally active USP7 inhibitor. P6620 specifically binds to USP7 and disrupts its interaction with LRRC41 . P6620 exhibits anticancer activity against hepatocellular carcinoma. P6620 enhances the antitumor effect of Lenvatinib ( HY-10981 ) in xenograft mouse models. P6620 can be used for the research of hepatocellular carcinoma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Deubiquitinase

Product Information

• Catalog No.: HY-183078
• CAS No.: 2009272-81-3
• Molecular Formula: C19H18N2O2
• Molecular Weight: 306.36
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source